Minutes of the Annual General Meeting (the ‘Meeting‘) of IGEA Pharma N.V., a public limited company (naamloze vennootschap), having its registered office in Amsterdam (the Netherlands), and address at: (2132 WT) Hoofddorp, Siriusdreef 17, registered with the Commercial Register of the Chamber of Commerce under number 70212821 (the ‘Company‘), held virtually on 9 July 2021 at 10:00 hours CEST.
Author: Leunar Miranda Leal
IGEA announces Annual General Meeting resolutions
Hoofddorp, the Netherlands, 9 July 2021. IGEA Pharma N.V. (SIX: IGPH) today announced that its shareholders followed the recommendations of the company. The minutes of the general meeting is available at https://www.igeapharma.nl/category/information-for-shareholders/
IGEA to launch the all equity offer to Blue Sky Natural Resources Ltd.
Hoofddorp, the Netherlands, 30 June 2021. IGEA Pharma N.V. (SIX: IGPH) today announced the launch of the all equity offer (the “Offer”) to Blue Sky Natural Resources Ltd.
Convening notice and agenda
Dear Shareholder,
The board of directors (the “Board“) of IGEA Pharmal N.V. (the “Company“) hereby invites you to attend the virtual annualgeneral meeting on 9 July 2021 (the “AGM“). The meeting will start at 10:00 hours CEST and is to be attended virtually Registration will start at 9:30 hours CEST.
IGEA announces changes in its board and other corporate updates
Hoofddorp, the Netherlands, 3June 2021. IGEA Pharma N.V. (SIX: IGPH) today announced the resignation of Mrs. Rosanna Squitti and Mr. Giovanni Ferrario from its board of directors. Mr. Ferrario resigned for personal reasons and Mrs. Squitti left the corporate body for continuing to serve as Chief Scientific Officer of the Company. The Board furthermore elected Mrs. Giovanna Puppo as new Chairman, substituting Mr. Francesco Mario Patrocollo who will newly assume the role of vice Chairman.
IGEA disclosed its Annual Report 2020
Hoofddorp, the Netherlands, 31 May 2021. IGEA Pharma N.V. (SIX: IGPH) today announced the disclosure if its Annual Report 2020.
IGEA to get SIX approval to delay the 2020 annual report disclosure
Hoofddorp, the Netherlands, 30 April 2021. IGEA Pharma N.V. (SIX: IGPH) today announced the grant of a temporary exemption from its disclosure obligations with respect to the 2020 annual report.
Minutes of the EGM 28 April 2021
Minutes of the Extraordinary General Meeting of IGEA Pharma N.V., a public limited company (naamloze vennootschap), having its registered office in Amsterdam (the Netherlands) and address at (2132 WT) Hoofddorp, Siriusdreef 17, registered with the Commercial Register of the Chamber of Commerce under number 70212821, held virtually on 28 April 2021.
IGEA announces extraordinary general meeting results
Hoofddorp, the Netherlands, 28 April 2021. IGEA Pharma N.V. (SIX: IGPH) today announced that the extraordinary general meeting unanimously approved all the Board of directors’ proposals. The minutes of the meeting is available at https://www.igeapharma.nl/category/information-for-shareholders/
IGEA to secure convertible bond commitment with Negma Group
Hoofddorp, the Netherlands, 15 April 2021. IGEA Pharma N.V. (SIX: IGPH) today announced the signing of a two-year convertible bond commitment with UAE-based Negma Group.